NCT06482723View on ClinicalTrials.gov

Efficacy and Performance Evaluation of mGlobal L+AS 20 mg/ml Hyaluronic Acid, for the Correction of Light to Moderate Wrinkles and Folds

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

August 3, 2023

Study Completion Date

August 3, 2023

Conditions
Skin AgingSkin Wrinkling
Interventions
DEVICE

mGlobal L+AS

The investigated dermal filler mGlobal L+AS is intended to be used as a temporary filler, administered by intradermal or subcutaneous injections, to correct small skin defects, such as wrinkles or scars.

Trial Locations (1)

1000

"Medical Center Ramus EOOD", Sofia

All Listed Sponsors
lead

Mesoestetic Pharma Group S.L.

INDUSTRY